The Water For Injection Market is estimated at US$33.9 billion in 2026 and is projected to grow at a CAGR of 8.4% to reach US$64.6 billion by 2034.
Its value chain includes purification equipment suppliers, pharmaceutical manufacturers, sterile packaging firms, contract manufacturers, hospitals, distributors, and regulatory quality partners. Core applications include drug formulation, sterile compounding, biotechnology manufacturing, hospital use, laboratory processes, and injectable medicine preparation.
This product will be delivered within 1-3 business days.
Market Overview
The Water For Injection Market covers high purity sterile water products and production systems used in pharmaceutical manufacturing, compounding, biotechnology processes, and clinical applications requiring stringent quality standards.Its value chain includes purification equipment suppliers, pharmaceutical manufacturers, sterile packaging firms, contract manufacturers, hospitals, distributors, and regulatory quality partners. Core applications include drug formulation, sterile compounding, biotechnology manufacturing, hospital use, laboratory processes, and injectable medicine preparation.
Key Companies Analysed
- Merck KGaA
- Sartorius
- Thermo Fisher Scientific
- Baxter
- B. Braun
- Fresenius Kabi
- Veolia Water Technologies
- STERIS
- Getinge
- Danaher
- Cytiva
- Pall Corporation
- Aqua-Chem
- Pharmatec
- MECO
- Consolidated Water
- Paul Mueller Company
- Aptar
- Recipharm
- Lonza
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Water For Injection Market Overview
3. Water For Injection Market Dynamics
4. Water For Injection Market Strategic Analysis
5. Global Water For Injection Market Size, Share and Forecast, 2025-2034
6. North America Water For Injection Market Outlook to 2034
7. Europe Water For Injection Market Outlook to 2034
8. Asia-Pacific Water For Injection Market Outlook to 2034
9. Middle East and Africa Water For Injection Market Outlook to 2034
10. South and Central America Water For Injection Market Outlook to 2034
11. Water For Injection Market Competitive Landscape
12. Appendix
Companies Mentioned
- Merck KGaA
- Sartorius
- Thermo Fisher Scientific
- Baxter
- B. Braun
- Fresenius Kabi
- Veolia Water Technologies
- STERIS
- Getinge
- Danaher
- Cytiva
- Pall Corporation
- Aqua-Chem
- Pharmatec
- MECO
- Consolidated Water
- Paul Mueller Company
- Aptar
- Recipharm
- Lonza
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 33.9 Billion |
| Forecasted Market Value ( USD | $ 64.6 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
